ES2166051T3 - Productos intermedios y procedimiento para preparar olanzapina. - Google Patents

Productos intermedios y procedimiento para preparar olanzapina.

Info

Publication number
ES2166051T3
ES2166051T3 ES97307383T ES97307383T ES2166051T3 ES 2166051 T3 ES2166051 T3 ES 2166051T3 ES 97307383 T ES97307383 T ES 97307383T ES 97307383 T ES97307383 T ES 97307383T ES 2166051 T3 ES2166051 T3 ES 2166051T3
Authority
ES
Spain
Prior art keywords
procedure
intermediate products
olanzapine
prepare olanzapine
prepare
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97307383T
Other languages
English (en)
Spanish (es)
Inventor
Charles Arthur Bunnell
Samuel Dean Larsen
John Richard Nichols
Susan Marie Reutzel
Gregory Alan Stephenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2166051(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2166051T3 publication Critical patent/ES2166051T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES97307383T 1996-09-23 1997-09-22 Productos intermedios y procedimiento para preparar olanzapina. Expired - Lifetime ES2166051T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
ES2166051T3 true ES2166051T3 (es) 2002-04-01

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97307383T Expired - Lifetime ES2166051T3 (es) 1996-09-23 1997-09-22 Productos intermedios y procedimiento para preparar olanzapina.

Country Status (35)

Country Link
US (1) US6020487A (forum.php)
EP (1) EP0831098B1 (forum.php)
JP (2) JP2001500877A (forum.php)
KR (1) KR100560015B1 (forum.php)
CN (1) CN1122036C (forum.php)
AR (1) AR013838A1 (forum.php)
AT (1) ATE209208T1 (forum.php)
AU (1) AU719441B2 (forum.php)
BR (1) BR9712100A (forum.php)
CA (1) CA2265712C (forum.php)
CO (1) CO4910140A1 (forum.php)
CZ (1) CZ299248B6 (forum.php)
DE (1) DE69708428T2 (forum.php)
DK (1) DK0831098T3 (forum.php)
EA (1) EA001642B1 (forum.php)
EG (1) EG23861A (forum.php)
ES (1) ES2166051T3 (forum.php)
HU (1) HU226484B1 (forum.php)
ID (1) ID27275A (forum.php)
IL (1) IL128962A (forum.php)
IN (1) IN187156B (forum.php)
MY (1) MY125565A (forum.php)
NO (1) NO323980B1 (forum.php)
NZ (1) NZ334448A (forum.php)
PE (1) PE110398A1 (forum.php)
PL (3) PL196068B1 (forum.php)
PT (1) PT831098E (forum.php)
RS (1) RS49598B (forum.php)
SI (1) SI0831098T1 (forum.php)
SV (1) SV1997000081A (forum.php)
TR (1) TR199900640T2 (forum.php)
TW (1) TW470746B (forum.php)
UA (1) UA59371C2 (forum.php)
WO (1) WO1998012199A1 (forum.php)
ZA (1) ZA978515B (forum.php)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018390A1 (en) * 2000-08-31 2002-03-07 Dr. Reddy's Laboratories Ltd. Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
EP1440074A1 (en) * 2001-10-29 2004-07-28 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
CH695862A5 (fr) 2001-12-24 2006-09-29 Sun Pharmaceutical Ind Ltd Forme cristalline I de la methyl-4-(4-methyl-1-piperazinyl) 10H-thieno [2,3-b] [1,5] benzodiazepine.
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
AU2003237305A1 (en) * 2002-05-31 2003-12-19 Geneva Pharmaceuticals, Inc. Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
AU2003300324A1 (en) * 2002-12-24 2004-07-22 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
JP2007511605A (ja) * 2003-11-18 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー オランザピン含有経皮薬物送達組成物
EP1611139B1 (en) * 2003-12-22 2008-06-04 Teva Pharmaceutical Industries Ltd. Methods of preparing olanzapine
ATE504588T1 (de) 2004-01-27 2011-04-15 Synthon Bv Stabile salze von olanzapin
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
DE05783995T1 (de) * 2004-07-14 2007-10-11 Shasun Chemicals and Drugs Ltd., Chennai Verbessertes verfahren zur herstellung von form i aus olanzapin
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
DE112005000641T5 (de) 2004-09-06 2007-09-06 Shasun Chemicals and Drugs Ltd., Chennai Neues Verfahren zur Herstellung einer pharmazeutisch reinen polymorphen Form I von Olanzapin
US7910577B2 (en) * 2004-11-16 2011-03-22 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
TW268005B (forum.php) * 1992-05-29 1996-01-11 Lilly Industries Ltd
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
IL128956A0 (en) * 1996-09-23 2000-02-17 Lilly Co Eli Olanzapine dihydrate D

Also Published As

Publication number Publication date
EP0831098A3 (en) 1998-04-29
PT831098E (pt) 2002-04-29
HU226484B1 (en) 2009-03-02
EA199900326A1 (ru) 1999-08-26
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
EP0831098B1 (en) 2001-11-21
HUP0000066A3 (en) 2000-11-28
IL128962A0 (en) 2000-02-17
ATE209208T1 (de) 2001-12-15
DE69708428T2 (de) 2002-07-04
ZA978515B (en) 1999-03-23
KR20000048520A (ko) 2000-07-25
NO991382D0 (no) 1999-03-22
HUP0000066A2 (hu) 2000-06-28
KR100560015B1 (ko) 2006-03-15
CZ99099A3 (cs) 1999-11-17
PL196069B1 (pl) 2007-12-31
AU719441B2 (en) 2000-05-11
AR013838A1 (es) 2001-01-31
EG23861A (en) 2007-11-18
CO4910140A1 (es) 2000-04-24
TR199900640T2 (xx) 1999-06-21
CN1234802A (zh) 1999-11-10
HK1009807A1 (en) 1999-06-11
NO323980B1 (no) 2007-07-30
PL194565B1 (pl) 2007-06-29
IN187156B (forum.php) 2002-02-16
US6020487A (en) 2000-02-01
YU15599A (sh) 2001-12-26
AU4484197A (en) 1998-04-14
SV1997000081A (es) 1999-01-14
DE69708428D1 (de) 2002-01-03
NO991382L (no) 1999-03-22
MY125565A (en) 2006-08-30
PE110398A1 (es) 1999-01-14
CZ299248B6 (cs) 2008-05-28
UA59371C2 (uk) 2003-09-15
PL332482A1 (en) 1999-09-13
CA2265712C (en) 2006-10-31
TW470746B (en) 2002-01-01
EA001642B1 (ru) 2001-06-25
CA2265712A1 (en) 1998-03-26
EP0831098A2 (en) 1998-03-25
BR9712100A (pt) 1999-08-31
IL128962A (en) 2003-01-12
ID27275A (id) 2001-03-22
JP2009242407A (ja) 2009-10-22
RS49598B (sr) 2007-06-04
DK0831098T3 (da) 2002-05-21
SI0831098T1 (en) 2002-04-30
PL196068B1 (pl) 2007-12-31
JP2001500877A (ja) 2001-01-23
CN1122036C (zh) 2003-09-24

Similar Documents

Publication Publication Date Title
ES2166051T3 (es) Productos intermedios y procedimiento para preparar olanzapina.
HN1997000072A (es) Procedimiento para la preparacion de sildenafil
PA8353701A1 (es) Procedimiento y forma cristalinas de 2-metil-tieno-benzodiacepina.
DK0752997T3 (da) Hidtil ukendte kationiske fosfolipider til transfektion
ES2180899T3 (es) Dihidrato d de olanzapina.
ES2178093T3 (es) Derivados de epotilon y su preparacion.
BR9809112B1 (pt) processo para preparação de clopidogrel.
BR9003077A (pt) Protetor higienico para calcinhas femininas
CU22953A3 (es) Procedimiento para la preparación de ácidos 8-metoxiquinoloncarboxílicos
ES2196110T3 (es) Composiciones de silicona reticulables, un procedimiento de preparacion y su uso..
SV1999000060A (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv
PT888291E (pt) Novos processos para a preparacao de intermediarios pesticidas
HN1997000127A (es) Procedimiento e intermedios para preparar derivados de cromanol sustituidos.
ES2109103T3 (es) Procedimiento para la preparacion de trialquilsilil-7 bacatina iii.
FI961378A0 (fi) Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi
ES2173399T3 (es) Procedimiento para la sintesis de benzotiofenos.
ES2176533T3 (es) Un procedimiento para la glicosidacion de derivados de colchicina y productos obtenido.
BR9612267A (pt) Processo para preparação de alquil éteres terciários
ES2062121T3 (es) Procedimiento para la preparacion de o-carboxipiridil- y o-carboxiquinolilimidazolinonas.
ES2145221T3 (es) Procedimiento para preparar nizatidina pura.
MX9301836A (es) Procedimiento para la obtencion de 2-amino-5-metil-piridina.
ES2106698T3 (es) Procedimiento microbiologico para la preparacion de 3-oxo-4-azaandrostan-3-onas 17beta-carboxi sustituidas.
AR019824A1 (es) Proceso para la preparacion de 2-cloro-3-hidroxipiridina
HN1998000013A (es) Metodo para la preparacion de (is,4q)-1-azabiciclo (2.2.1) heptano 3-uno y (1r,45), 1-azabiciclo (2.2.1) heptano 3-uno.
BR9601581A (pt) Processo para preparaç o de n-fosfonometilglicina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 831098

Country of ref document: ES